💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Eagle Pharmaceuticals, Inc. (EGRX)
« Back to company indexEGRX Chatter Timeline
Stock Ticker for EGRX
Most Active Tweeters for EGRX
| User | Tweets |
|---|---|
| @TortozaLeandro | 7 |
| @ShortAlgoTrades | 3 |
| @StockNewsBot2 | 1 |
| @FlashAlert_me | 1 |
| @LeeSinTrade1 | 1 |
Recent Tweets for EGRX
 |
@ShortAlgoTrades $EGRX Waiting for Buy signal , https://t.co/Z6zmK3jPhv December 2nd 2021, 7:12pm |
 |
@VatqLu $EGRX Waiting for Buy signal , https://t.co/uSaRH9YzNF December 2nd 2021, 7:12pm |
 |
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/FIchbgs4Dp December 2nd 2021, 6:12pm |
|
@ShortAlgoTrades $EGRX Awaiting Buy Signal. Stock Trading Ideas by https://t.co/jpmUt7BvVp https://t.co/5z1JXF89dA December 2nd 2021, 2:12pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/xau05RkpcU December 1st 2021, 6:12pm |
 |
@LeeSinTrade1 $EGRX Awaiting buy signal. Algo Trading Ideas by https://t.co/z9Zossz5Nf https://t.co/AI4qGpbJVy November 29th 2021, 12:11pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/eX5vdRmMDX November 28th 2021, 8:11pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/TGggmMiTPD November 27th 2021, 4:11pm |
|
@ShortAlgoTrades $EGRX Awaiting buy signal. Stock trading ideas by https://t.co/jpmUt7BvVp https://t.co/k8sscYQECH November 26th 2021, 2:11pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/FwtQ9xvDzx November 24th 2021, 8:11pm |
 |
@A1Syad $EGRX Awaiting buy signal. Stock Trading Ideas by https://t.co/1MjnDHV7ua https://t.co/E0CtxNq6BO November 22nd 2021, 5:11pm |
 |
@SmallCapsDaily $EGRX Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 Business Wire… https://t.co/W9P1P2YAWf November 22nd 2021, 3:11pm |
 |
@equity_newswire $EGRX Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/W6IQFwIooa November 22nd 2021, 2:11pm |
 |
@gcassidy718 $EGRX Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/QrJkZKNVBr November 22nd 2021, 1:11pm |
 |
@otcdynamics $EGRX Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/TIXxLJzDHD November 22nd 2021, 12:11pm |
 |
@FlashAlert_me $EGRX [15s. delayed]: Issued Press Release on November 22, 06:50:00: Eagle Pharmaceuticals to Present at Piper Sand… https://t.co/GGjWeUytBZ November 22nd 2021, 11:11am |
 |
@StockNewsBot2 $EGRX Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/zSFlwtgmUw November 22nd 2021, 11:11am |
 |
@phasefivebot $EGRX Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/mdtgQkjDDs November 22nd 2021, 11:11am |
 |
@stock_titan $EGRX Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 https://t.co/srInpLFxnk November 22nd 2021, 11:11am |
 |
@newsfilterio Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021 $EGRX https://t.co/pNhs4S5RM9 November 22nd 2021, 11:11am |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/ngcTLq55O3 November 21st 2021, 8:11pm |
 |
@Tickeron $EGRX's 10-day Moving Average moved below its 50-day Moving Average on October 27, 2021. View odds for this and oth… https://t.co/MPk7GqGThI November 21st 2021, 4:11pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/GcpawkXItX November 20th 2021, 8:11pm |
|
@LeeSinTrade1 $EGRX Awaiting Buy Signal. Stock Trading Ideas by https://t.co/z9Zossz5Nf https://t.co/m9HdaRtaYg November 15th 2021, 1:11pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/KsYeohIhAb November 14th 2021, 8:11pm |
|
@Tickeron $EGRX's 10-day Moving Average crossed below its 50-day Moving Average on October 27, 2021. View odds for this and o… https://t.co/02scSZUeVC November 14th 2021, 2:11pm |
|
@TortozaLeandro $EGRX Awaiting for Buy signal on EGRX with https://t.co/BVorhZSlcz https://t.co/oMwroMl2In November 13th 2021, 3:11pm |
 |
@LevFinCynic Interesting disclosure (guess?) by $EGRX CEO on $ENDP Vaso : "As you know, Endo has settlements and we don't know… https://t.co/8ywYvQwhG9 November 10th 2021, 2:11pm |
 |
@investor_feed $EGRX 10-Q Eagle Pharmaceuticals (9 Nov, 4:22pm) ? 2021 Q3 Earnings https://t.co/3RQG2iJllf #EGRX #10Q… https://t.co/vjwvINWKK5 November 9th 2021, 9:11pm |
 |
@EarningsAlley Eagle Pharmaceuticals, Inc. $EGRX held an earnings call on 11/9/2021. Here are the highlights: November 9th 2021, 8:11pm |
 |
@SeekingAlpha $EGRX - Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tariff on Q3 2021 Results - Earnings Call Transcript.… https://t.co/3XnnD039Rj November 9th 2021, 6:11pm |
|
@investor_feed $EGRX 8-K Eagle Pharmaceuticals (9 Nov, 12:46pm) ? Eagle Pharmaceuticals Reports Third Quarter 2021 Results… https://t.co/tjJSfhRk1A November 9th 2021, 5:11pm |
 |
@quantisnow $EGRX ? Eagle Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial St… https://t.co/GJxS6jCIPp November 9th 2021, 5:11pm |
 |
@SwingTradeBot Reversed from Down today: $EGRX ... https://t.co/uuYYhupj1A November 9th 2021, 4:11pm |
|
@SmallCapsDaily $EGRX Eagle Pharmaceuticals Reports Third Quarter 2021 Results Business Wire https://t.co/AYGLW1wjkC… https://t.co/7bMClrwZ2k November 9th 2021, 3:11pm |
|
@gcassidy718 $EGRX Eagle Pharmaceuticals Reports Third Quarter 2021 Results https://t.co/QC2jCagp50 November 9th 2021, 3:11pm |
|
@equity_newswire $EGRX Eagle Pharmaceuticals Reports Third Quarter 2021 Results https://t.co/02yiU62fAI November 9th 2021, 2:11pm |
|
@LevFinCynic Re $ENDP / $EGRX : big if true https://t.co/Yr08QkWBrP November 9th 2021, 1:11pm |
 |
@Estimize $EGRX misses the Estimize EPS Consensus by 36c and the Estimize Revenue Consensus by $7.47M. Reports FQ3 earnings o… https://t.co/e1LpE26jzL November 9th 2021, 1:11pm |
|
@Estimize $EGRX reports FQ3 earnings of 56c EPS and $39.85M Revs - https://t.co/7ZxHDhwQun November 9th 2021, 1:11pm |
 |
@MarcJacksonLA $EGRX Eagle Pharmaceuticals Reports Third Quarter 2021 Results https://t.co/NLC0Gq6SWj November 9th 2021, 12:11pm |
 |
@63_hyacinth Eagle Pharmaceuticals reports Q3 adjusted EPS 56c, consensus 83c $EGRX November 9th 2021, 11:11am |
|
@FlashAlert_me $EGRX [15s. delayed, acc.~90%, always check] Earnings Release November 09, 06:50:00: Q3: GAAP EPS of -$0.43, Revenu… https://t.co/qKtUndHtsJ November 9th 2021, 11:11am |
|
@FlashAlert_me $EGRX [15s. delayed]: Issued Press Release on November 09, 06:50:00: Eagle Pharmaceuticals Reports Third Quarter 20… https://t.co/udkcC8L1fH November 9th 2021, 11:11am |
 |
@MarketCurrents $EGRX - Eagle Pharmaceuticals EPS misses by $0.27, misses on revenue https://t.co/54pgttz7R0 November 9th 2021, 11:11am |
|
@newsfilterio Eagle Pharmaceuticals Reports Third Quarter 2021 Results $EGRX https://t.co/1IoauQJKQk November 9th 2021, 11:11am |
|
@StockNewsBot2 $EGRX Eagle Pharmaceuticals Reports Third Quarter 2021 Results https://t.co/cHAdgyXHVz November 9th 2021, 11:11am |
|
@quantisnow $EGRX ? Eagle Pharmaceuticals Reports Third Quarter 2021 Results https://t.co/VWpeFRKI84 45 seconds delayed. November 9th 2021, 11:11am |
|
@phasefivebot $EGRX Eagle Pharmaceuticals Reports Third Quarter 2021 Results https://t.co/swFrqsdgXW November 9th 2021, 11:11am |
|
@stock_titan $EGRX Eagle Pharmaceuticals Reports Third Quarter 2021 Results https://t.co/V8X3dai5FK November 9th 2021, 11:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?